Canaccord Upgrades NuVasive to Buy

by Juan Lopez, Benzinga Staff Writer

January 23, 2012 8:19 AM | 6 seconds read | Make a Comment

Canaccord has upgraded NuVasive

NUVA

from Hold to Buy and maintains its $19 price target.

Posted In: Upgrades Price Target Pre-Market Outlook Analyst Ratings Canaccord

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.